Menu
GeneBe

1-74199727-A-G

Variant summary

Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PM2PP3

The NM_003838.5(FPGT):c.146A>G(p.Gln49Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 33)

Consequence

FPGT
NM_003838.5 missense

Scores

6
6
2

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 7.97
Variant links:
Genes affected
FPGT (HGNC:3825): (fucose-1-phosphate guanylyltransferase) L-fucose is a key sugar in glycoproteins and other complex carbohydrates since it may be involved in many of the functional roles of these macromolecules, such as in cell-cell recognition. The fucosyl donor for these fucosylated oligosaccharides is GDP-beta-L-fucose. There are two alternate pathways for the biosynthesis of GDP-fucose; the major pathway converts GDP-alpha-D-mannose to GDP-beta-L-fucose. The protein encoded by this gene participates in an alternate pathway that is present in certain mammalian tissues, such as liver and kidney, and appears to function as a salvage pathway to reutilize L-fucose arising from the turnover of glycoproteins and glycolipids. This pathway involves the phosphorylation of L-fucose to form beta-L-fucose-1-phosphate, and then condensation of the beta-L-fucose-1-phosphate with GTP by fucose-1-phosphate guanylyltransferase to form GDP-beta-L-fucose. Alternative splicing results in multiple transcript variants. Read-through transcription also exists between this gene and the neighboring downstream TNNI3 interacting kinase (TNNI3K) gene. [provided by RefSeq, Dec 2010]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 3 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.786

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
FPGTNM_003838.5 linkuse as main transcriptc.146A>G p.Gln49Arg missense_variant 2/4 ENST00000370898.9
FPGT-TNNI3KNM_001112808.3 linkuse as main transcriptc.146A>G p.Gln49Arg missense_variant 2/27

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
FPGTENST00000370898.9 linkuse as main transcriptc.146A>G p.Gln49Arg missense_variant 2/41 NM_003838.5 P1

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD4 exome
Cov.:
30
GnomAD4 genome
Cov.:
33

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsApr 18, 2023The c.185A>G (p.K62R) alteration is located in exon 2 (coding exon 2) of the FPGT-TNNI3K gene. This alteration results from a A to G substitution at nucleotide position 185, causing the lysine (K) at amino acid position 62 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.88
BayesDel_addAF
Pathogenic
0.38
D
BayesDel_noAF
Pathogenic
0.31
Cadd
Pathogenic
27
Dann
Uncertain
1.0
Eigen
Pathogenic
0.70
Eigen_PC
Uncertain
0.65
FATHMM_MKL
Uncertain
0.94
D
LIST_S2
Uncertain
0.86
D;D;D;D;D;D;D;D;D;D;D
M_CAP
Benign
0.069
D
MetaRNN
Pathogenic
0.79
D;D;D;D;D;D;D;D;D;D;D
MetaSVM
Uncertain
0.13
D
MutationTaster
Benign
0.99
D;D;D;D;D;D;N;N
REVEL
Pathogenic
0.70
Sift4G
Uncertain
0.0080
D;D;D;D;D;D;D;D;D;D;D
Vest4
0.87
MutPred
0.65
.;.;Gain of ubiquitination at K48 (P = 0.1222);.;Gain of ubiquitination at K48 (P = 0.1222);.;.;Gain of ubiquitination at K48 (P = 0.1222);Gain of ubiquitination at K48 (P = 0.1222);Gain of ubiquitination at K48 (P = 0.1222);Gain of ubiquitination at K48 (P = 0.1222);
MVP
0.93
MPC
0.093
ClinPred
0.99
D
GERP RS
4.8
Varity_R
0.24
gMVP
0.78

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chr1-74665411; API